ArticleOpen access2026
International Journal of Clinical and Medical Research · vol. 3 (1) · 34-39
Arthritis represents a heterogeneous group of inflammatory and degenerative joint disorders characterized by persistent inflammation, oxidative stress, cartilage degradation, synovial dysfunction and progressive impairment of joint integrity. Rheumatoid Arthritis (RA) and Osteoarthritis (OA), although distinct in etiology, share several pathological mechanisms involving excessive production of Reactive Oxygen Species (ROS), mitochondrial dysfunction, inflammatory cytokine activation and dysregulation of redox-sensitive signaling pathways [1-4]. The nuclear factor erythroid 2-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1 (Keap1) pathway is a major endogenous defense mechanism responsible for maintaining cellular redox homeostasis. Under basal conditions, Keap1 promotes Nrf2 degradation; however, oxidative or electrophilic stress disrupts this interaction, allowing Nrf2 to accumulate and translocate into the nucleus, where it activates antioxidant response element (ARE)-dependent genes, including heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione-related enzymes [5,6]. Increasing evidence indicates that impaired or insufficient Nrf2 activity contributes to persistent oxidative stress and inflammation in arthritic joints [1,7]. Nrf2 also interacts with major inflammatory pathways, particularly nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK) and NLRP3 inflammasome signaling [8]. Nanotechnology offers an opportunity to improve the delivery, stability, bioavailability and tissue targeting of therapeutic agents capable of modulating redox and inflammatory pathways. Among different nanomaterials, silver nanoparticles (AgNPs) have attracted considerable interest because of their antimicrobial, anti-inflammatory, antioxidant and immunomodulatory properties [9-11]. Experimental studies have demonstrated that AgNPs can reduce inflammatory cytokines, regulate NF-κB and MAPK signaling, influence macrophage polarization and alleviate inflammatory tissue injury [9,10]. In experimental RA, targeted folic-acid-modified AgNPs have demonstrated the ability to interact with inflammatory macrophages, promote macrophage apoptosis and repolarization and reduce disease severity [12]. Nevertheless, the relationship between AgNP exposure, oxidative signaling and Nrf2-Keap1 activation is complex and excessive nanoparticle-induced oxidative stress may also produce adverse biological effects. This review examines the role of the Nrf2-Keap1 pathway in arthritis, evaluates nanoparticle-based strategies for modulating redox and inflammatory mechanisms and critically discusses the therapeutic potential and safety considerations of AgNPs. Particular emphasis is placed on the potential intersection between AgNP-mediated redox regulation, Nrf2-Keap1 signaling, NF-κB inhibition, macrophage polarization and joint protection.
Nrf2/Keap1 pathwayarthritisrheumatoid arthritisosteoarthritis
ArticleOpen access2026
International Journal of Clinical and Medical Research · vol. 3 (1) · 47-50
Alzheimer Disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β deposition, tau pathology, synaptic dysfunction, neuronal injury and cerebral atrophy. Positron Emission Tomography (PET) has transformed AD evaluation by enabling in-vivo visualization of molecular and metabolic abnormalities. 18F-Fluorodeoxyglucose (FDG) PET evaluates cerebral glucose metabolism, amyloid PET identifies fibrillar amyloid-β and tau PET provides information about neurofibrillary pathology. This review examines diagnostic and prognostic applications of PET in AD, particularly in mild cognitive impairment, atypical dementia, differential diagnosis, disease staging, progression prediction and treatment selection. Evidence indicates that amyloid PET is highly useful for establishing amyloid pathology, whereas tau PET is more closely associated with disease stage and clinical severity. FDG PET remains valuable for identifying patterns of neurodegeneration and distinguishing AD from other dementias. With the emergence of disease-modifying anti-amyloid therapies, molecular confirmation has become increasingly relevant to treatment decisions. Important limitations include cost, availability, radiation exposure, tracer-specific limitations, mixed pathology and interpretation variability. Future integration of PET with MRI, blood biomarkers and artificial intelligence may improve individualized diagnosis, prognosis and therapeutic monitoring.
Alzheimer's diseasepositron emission tomographyamyloid PETtau PET
ReviewClosed2026
Pathology - Research and Practice · vol. 286 · 156609-156609
Ras signalinginfectious disease pathologyhost-pathogen interactionMAPK/ERK pathway
ArticleClosed2026
Tissue and Cell · vol. 103 · 103731-103731
garlic oilcardioprotectionoxidative stressinflammation
ArticleOpen access2026
Journal of Medical Case Reports · vol. 20 (1)
BACKGROUND: Congenital bronchoesophageal fistula (BEF) is a rare communicating bronchopulmonary foregut malformation (CBPFM) characterized by an abnormal connection between the esophagus and a bronchial segment or lung tissue. While esophageal atresia (EA), with or without tracheoesophageal fistula, occurs in approximately 2-3 per 10,000 live births, EA associated with CBPFM/congenital BEF is far rarer, with no established population-based incidence and only several dozen reported CBPFM cases in the literature. Most congenital BEFs present in childhood or adulthood with chronic, nonspecific respiratory symptoms and recurrent infections, whereas neonatal presentations are typically linked to major associated anomalies such as EA. Importantly, complex neonatal constellations-particularly those combining EA with bronchial atresia and a severely hypoplastic, non-aerated lung-may represent an atypical CBPFM variant that does not fit neatly within traditional BEF classification schemes. CASE PRESENTATION: We report a premature Arab female infant born at 32 weeks gestation who presented with respiratory distress, copious oral secretions, and radiographic features of EA with complete right hemithorax opacification and mediastinal shift to the right on a chest X-ray (CXR). After initial stabilization, a gastrostomy tube was inserted. Contrast studies via the gastrostomy tube and computed tomography angiography (CTA) revealed EA with a fistulous communication between the distal esophagus and right bronchial structures, along with a severely hypoplastic right lung. On day 33 of life, the patient underwent surgery. Intraoperative findings confirmed a fistula between the atretic right main bronchus and the lower esophagus, with a nonfunctioning right lung. Definitive EA repair and right pneumonectomy were performed. Histopathology revealed bronchial atresia involving the right main bronchus with right pulmonary hypoplasia. The postoperative course was complicated by pneumothorax, pneumomediastinum, sepsis, and persistent anastomotic leakage, and was managed conservatively with drainage, antimicrobial/antifungal therapy, and prolonged total parenteral nutrition. Serial contrast studies confirmed gradual leak resolution, and oral feeding was started by postoperative day 87. On follow-up, the infant initially maintained oxygen saturation and stable vital signs in room air without respiratory support; however, feeding advancement was complicated by recurrent vomiting and suspected delayed gastric emptying/gastroparesis. Despite combined parenteral and enteral nutrition and a trial of continuous orogastric tube feeding, the infant later developed severe septic shock requiring intravenous antibiotics and ventilatory support. The septic shock was refractory, and the patient died at 5 months of chronological age, corresponding to approximately 3 months corrected age. CONCLUSION: This case represents an atypical congenital BEF variant in which EA coexists with a distal esophageal fistula to an atretic right main bronchus and a severely hypoplastic, non-aerated right lung, highlighting a classification-challenging phenotype. It underscores the crucial role of early targeted imaging in neonates with suspected EA and unilateral lung hypoplasia/atresia. Advanced imaging enables accurate diagnosis and guides surgical planning, while the fatal follow-up course highlights the clinical vulnerability of these patients and the need for careful long-term multidisciplinary monitoring.
esophageal atresiaright lung hypoplasiapreterm infantsneonatal respiratory distress
ArticleOpen access2026
Neurosciences · vol. 31 (3) · 230-243
Objective: To evaluate and compare the safety and effectiveness of antipsychotic medications for the treatment of hiccups, thereby guiding clinicians toward evidence-based treatment guidelines. Hiccups are often benign and self-limiting; however, they can become persistent and intractable, adversely affecting the quality of life. Antipsychotics have been identified as a therapeutic option for the management of hiccups; however, the available evidence supporting their safety and efficacy has not been synthesized. Methods: This review utilized the revised Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The Cochrane Risk of Bias Assessment Tool was modified to evaluate the quality of the selected studies. The search strategy included terms related to or describing hiccups and antipsychotics. Research articles in English published between 1974 and March 2024 were searched in different databases. Duplicates and eligibility criteria were used to screen articles. Results: A search of Medline, Scopus, and Web of Science yielded 1537 articles, of which 1042 were retained after removing duplicates, and 16 met the inclusion criteria. The studies that met the inclusion criteria were all case reports, case series, or retrospective studies, with no randomized trials. A few antipsychotics have been shown to totally or partially alleviate hiccups. Nine studies reported that hiccups were completely resolved in patients treated with 10-25 mg oral and intramuscular chlorpromazine, 1-2 mg oral and intramuscular haloperidol, 2.5-10 mg oral olanzapine, 25-150 mg tetrabenazine, and 3 mg oral risperidone. Adverse events were documented in 7 of the studies. Conclusion: Chlorpromazine and olanzapine are effective antipsychotics for hiccup treatment. However, more evidence-based studies and controlled clinical trials are needed to confirm the efficacy and minimize the side effects. PROSPERO registration: (CRD42024511626).
hiccupsantipsychotic drugschlorpromazinehaloperidol
ArticleOpen access2026
Toxics · vol. 14 (7) · 550-550
The safety profile for bio-derived phenols post-oxidation and their related antioxidant/redox potential remain largely under-explored. Oxidation by fungi, in terms of environmental impacts via fungal oxidation by enzymes, remains an attractive strategy under milder conditions, since it is one route by which many naturally occurring lignocellulosic phenols are modified; thus, an immediate need still exists for characterizing the effects that these modified phenolic compounds may have. METHODOLOGY: We examined four different biomass-derived phenolics-vanillin, ferulic acid, syringaldehyde and guaiacol-that were oxidized with fungal laccase and characterized their effects on normal human lung fibroblasts and levels of cellular oxidative stress. Laccase activity was evaluated via the ABTS method and through simple observation and UV-Vis spectroscopic scanning of the phenolics in question, and compared with the untreated version of each phenolic. In addition to assessing the cytotoxic effect and oxidative stress generated by the phenols alone, an ELISA-based measurement assay was used to investigate the relative abundance of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and reduced glutathione (GSH) in the human normal lung fibroblast cell line under varying treatment regimes, complemented by phase-contrast microscopy. Scores integrating the biomarkers were analyzed via clustering, PCA, radar and Pearson correlation analyses, to discern distinct trends in antioxidant potential after laccase conversion. OBSERVATIONS: Each of the four tested phenolics demonstrated the presence of laccase activity, leading to substantial differences in visible appearance compared with the control and characteristic absorbance shifts at differing wavelengths from the original molecule. Cell viability dropped dramatically as phenol concentration was increased and the untreated phenolics resulted in diminished confluence and induced greater levels of oxidative damage, from guaiacol and syringaldehyde. Laccase treatment resulted in higher MTT reduction activity and improved cellular morphology compared with the corresponding untreated phenolic compounds. Untreated phenols induced the highest levels of MDA, while decreasing SOD, CAT, GPx and GSH levels. Post-oxidation with laccase, there were lower amounts of lipid peroxidation, along with improved levels of antioxidant activity compared with the control phenol. Multi-technique analyses show clear distinctness between the untreated and laccase-converted phenolic groups. Clustering with multivariate techniques separated all cell groups in line with control samples, grouping the laccase-converted treatments towards the middle and displaying an inverse relationship between MDA and the antioxidant markers. CONCLUSIONS: Laccase conversion markedly decreases the adverse effects that bio-derived phenols have on normal cell viability and induces fewer detrimental effects on the cellular redox balance. This is a critical discovery in terms of finding greener methods by which to upgrade bio-derived substances as we research these lignocellulosic phenols. By employing ELISA-based measurements along with multiple analysis techniques, we present a suitable paradigm for studying biological effects in all bio-based goods intended for pharmaceuticals, packaging materials, nutraceuticals or a host of different applications.
fungal oxidationvanillinferulic acidsyringaldehyde
RetractionOpen access2026
Biomedicine & Pharmacotherapy · vol. 201 · 119684-119684
bone marrow mesenchymal stem cellsexosomes
PreprintOpen (repository)2026
Research Square
Abstract This paper introduces an Intelligent and Secure Big Data Analyt-ics framework based on Explainable Hyper-Heuristic Optimization for dynamic blockchain transaction fee prediction and scheduling in distributed systems. The proposed framework is motivated by the volatility and complexity of large-scale blockchain fee markets, such as Ethereum’s EIP-1559 mechanism, which generate high-dimensional, time-varying transactional data characteristic of modern distributed and IoT-enabled ecosystems. The framework integrates a machine learning–based fee prediction module with an adaptive hyper-heuristic optimization engine that solves a mixed-integer scheduling problem over large-scale blockchain transaction datasets. In addition, a SHAP-based explainability layer is incorporated to support transparent, interpretable, and auditable decision-making, enabling trustworthy analytics in secure distributed environments. Experimental evaluation using six months of Ethereum mainnet data demonstrates that the proposed approach reduces median transaction costs by up to 14.8% and improves average confirmation delays by 8.3% compared with heuristic and fixed-fee baselines. Secure Big Data Analytics for Blockchain Scheduling Further analysis highlights the benefits of combining predictive analyt-ics, adaptive heuristic selection, and exact refinement under dynamic network conditions, while explainability results identify key transac-tional and network features influencing fee behavior and scheduling decisions. Overall, the proposed framework advances intelligent and secure big data analytics for distributed systems by improving efficiency , transparency, and trust in decentralized transaction management , with applications in wallets, decentralized applications, and latency-sensitive financial services. Future work will extend the framework to multi-chain environments, integrate Layer-2 scaling solutions, and explore real-time deployment in production blockchain systems.
transaction schedulingexplainable AISHAPEIP-1559
ArticleOpen access2026
BMC Public Health · vol. 26 (1)
BACKGROUND: Mental health disorders such as depression, anxiety, and stress are significant public health concerns, affecting 10-20% of adolescents globally. In Saudi Arabia and Malaysia, youth mental health issues are growing, yet Mental Health Literacy remains low. MHL encompasses recognizing mental disorders, seeking appropriate help, and understanding treatment options. Reusable Learning Objects (RLO), offer a promising solution to provide evidence-based education. However, studies on the effectiveness of RLO in different cultural settings are limited. This study employed a protocol of a cross-country comparison study aimed at evaluating the potential effectiveness of RLO in supporting Mental Health Literacy among youth in Saudi Arabia and Malaysia. METHODS: A quasi-experimental design was employed among youth aged 16-24 years in two cities, Riyadh, Saudi Arabia, and Kuala Lumpur, Malaysia. RLO was developed using the ASPIRE methodology, and a validated English and Arabic MHL questionnaire was used in the study. Participants were assigned to intervention and control groups. The intervention group engaged with RLOs, while the control group completed the questionnaire without RLO exposure. Data were collected at baseline and post-intervention. Wilcoxon signed-rank tests compared baseline and post-intervention scores within groups, while Mann-Whitney U tests compared post-intervention change scores between countries. RESULTS: Wilcoxon signed-rank analyses revealed significant improvements in MHL among participants in Saudi Arabia and Malaysia. In Saudi Arabia, improvements were observed across all domains, including a reduction in erroneous beliefs (p = .021). Mann-Whitney U tests showed that Malaysian participants achieved greater gains in mental health disorder knowledge (p < .001) and overall MHL (p = .002) compared to Saudi Arabian participants, with small-to-medium effect sizes. In Malaysia, large gains were found in mental health disorder knowledge, help-seeking/first aid skill, self-help strategies, and total MHL (p < .001), whereas changes in erroneous beliefs were not significant. CONCLUSIONS: These findings highlight the promise of scalable, interactive RLOs for enhancing youth MHL in diverse cultural contexts, informing national digital mental health promotion strategies, school curricula integration, and policies to reduce stigma and improve early help-seeking in resource-constrained settings.
mental health literacyreusable learning objectsyouth mental healthadolescents
ArticleClosed2026
Journal of Family Medicine and Preventive Medicine · vol. 3 (2) · 1-1
Helicobacter pylori infectiontreatment guidelineseradication therapypeptic ulcer
ReviewOpen access2026
Frontiers in Medicine · vol. 13 · 1847464-1847464
Introduction: Developmental dyslexia refers to a common neurodevelopmental disorder, which impairs the accuracy and fluency of reading, and early identification is vital for initiating timely intervention. Nonetheless, the traditional methods of formal assessment are time- and resource-intensive, which limits their scalability. Machine-learning approaches and eye-tracking technologies provide objective, data-driven solutions for dyslexia screening. This research integrates current evidence on eye-movement-based and emerging multimodal computational methods for dyslexia screening, risk identification, and algorithmic classification during reading tasks. Methods: PubMed, Scopus, Web of Science, and CINAHL were searched systematically to identify studies published between January 2015 and March 2026. Eligible studies included analysis of eye-movement obtained via eye tracking or electrooculography (EOG), with or without predictive modeling. Methodological quality was assessed using JBI, PROBAST, ROBINS-I, and COSMIN tools. Results: = 2). The sample sizes ranged from small experimental cohorts (<20 participants) to larger datasets (>300 participants). In the literature, dyslexic readers were consistently found to exhibit longer fixation durations, increased regression behavior and reduced saccadic efficiency. Machine-learning algorithms using fixation, saccade, scan path, and signal-based features demonstrated classification accuracies ranging from approximately 80 to 95% with some studies reporting values approaching 99% under specific experimental conditions. Discussion: Nevertheless, there was a significant heterogeneity in datasets, feature extraction methods, outcome definitions and validation schemes. Notably, numerous studies used proxy diagnostic labels, small or internally derived datasets, and internal cross-validation, which introduces the risk of overfitting and performance inflation. Explicit multimodal or multi-source modeling was identified in three of 23 studies involving combinations of gaze data with demographic, cognitive, linguistic, VR-bed, text-derived, saliency-map, or CNN-based features. Two additional studies used EOG as an alternative eye-movement signal modality rather than true multi-source fusion. Therefore, the evidence base remains dominated by eye-movement and gaze-derived approaches, while multimodal evidence should be interpreted as emerging and exploratory. Altogether, eye-movement based computational systems are a promising, non-invasive method for scalable dyslexia screening. Systematic review registration: PROSPERO, identifier (RD42061332527).
developmental dyslexiadyslexia screeningeye movementseye tracking
ArticleOpen access2026
BMC Health Services Research · vol. 26 (1)
BACKGROUND: Women in Sudan face significant challenges in access to healthcare due to financial hardship, male decision-making influence and geographic limitations, contributing to delayed care-seeking barriers to maternal and reproductive healthcare, and persistent health inequities. METHODOLOGY: A community-based cross-sectional study was conducted among 760 Sudanese women aged 18 years and above using a structured interviewer-administered questionnaire. Data were collected through face-to-face interviews across urban and rural areas, and associations with healthcare accessibility were examined using binary logistic regression analysis. RESULTS: Financial limitations were a major barrier, with 24.8% of women reporting rare or no financial ability to access healthcare. Additionally, 32.1% always required male permission to seek care and 7.6% experienced healthcare delays due to male family members' decisions. Women living more than 10 km from a healthcare facility were 7.1 times more likely to report inadequate access. Nearly half of the participants 49.6% strongly disagreed that male family members understood the importance of timely healthcare. CONCLUSION: Women's access to healthcare in Sudan remains constrained by interconnected economic, sociocultural, and geographic barriers. The findings highlight that urgent policy reforms are needed to expand affordable and geographically accessible healthcare services, strengthen women's financial and decision-making autonomy, and promote community-based interventions that engage men in supportive healthcare practices. CLINICAL TRIAL NUMBER: Not applicable.
women's health care accessSudangender barriersfinancial barriers to care
RetractionOpen access2026
Biomedicine & Pharmacotherapy · vol. 201 · 119641-119641
mesenchymal stem cell-derived exosomesAlzheimer's diseaseautophagyinsulin
ArticleOpen access2026
International Journal of Molecular Sciences · vol. 27 (12) · 5450-5450
Differentiating inflammatory bowel disease (IBD) from diarrhea-predominant irritable bowel syndrome (IBS-D) remains a major clinical challenge due to overlapping symptoms and the limited specificity of single biomarkers. A reliable, non-invasive multimarker approach is needed to improve diagnostic accuracy and reduce unnecessary endoscopic procedures. To evaluate the diagnostic performance of serum interleukin-17A (IL-17A), neutrophil-to-albumin ratio (NAR), and fecal calprotectin (FCP), individually and in combination, for discriminating IBD from IBS-D and healthy controls in Egyptian patients. In this case–control study, 300 participants (100 with IBD, 100 with IBS-D, and 100 healthy controls) were enrolled. Serum IL-17A, NAR, and FCP were measured, and subgroup analysis was performed for infected and non-infected IBS-D patients. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis, with optimal cutoffs determined by the Youden index. A combined biomarker model was constructed using logistic regression. All biomarkers demonstrated a significant stepwise increase from healthy controls to IBS-D and IBD (p < 0.001). IL-17A, NAR, and FCP were elevated in IBS-D compared with controls, indicating low-grade inflammation, but were highest in IBD. No significant differences were observed between infected and non-infected IBS-D patients. Among individual markers, NAR showed the highest diagnostic accuracy (AUC = 0.923), followed by FCP (AUC = 0.884) and IL-17A (AUC = 0.859). The combined model significantly improved performance (AUC = 0.973), achieving 89% sensitivity and 96% specificity. IBS-D is associated with measurable systemic and intestinal inflammation independent of infection status. The combined biomarker model integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising discriminatory performance for differentiating IBD from IBS-D. These findings suggest the potential applicability of combined non-invasive biomarkers in future diagnostic stratification approaches. However, the model was developed and evaluated within a single cohort, and external validation in independent populations is required before future potential clinical application. A multimarker diagnostic panel integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising diagnostic performance for differentiating inflammatory bowel disease from IBS-D. The combined model may contribute to future diagnostic stratification strategies in patients with chronic diarrhea. However, these findings were derived from a single cohort and require validation in independent populations before broader clinical application.
inflammatory bowel diseasediarrhea-predominant irritable bowel syndromeIL-17Aneutrophil-to-albumin ratio